Ling Han

机构：Shanghai University, Guangzhou University of Chinese Medicine, Jinan University, National Medical Products Administration, Wenzhou Medical University, Southern University of Science and Technology, Key Laboratory of Guangdong Province, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Gilead Sciences (Canada), Guangdong Provincial Hospital of Traditional Chinese Medicine, Gilead Sciences (United Kingdom), Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Gilead Sciences (Australia) · ORCID：0000-0002-6168-8828

发表论文 158 篇 · 总被引 4662 次 · h-index 34

代表论文

• Design, Synthesis, and Biological Evaluation of 1,3,4-Thiadiazole Derivatives as Novel Potent Peptide Deformylase Inhibitors for Combating Drug-Resistant Gram-Positive and -Negative Bacteria (2025 · Journal of Medicinal Chemistry · 被引 10)
• Causal associations between psoriasis, eczema, urticaria, and mental illness: A bidirectional Mendelian randomization study of the European population (2024 · Medicine · 被引 10)
• Anti-psoriasis effect of 18β-glycyrrhetinic acid by breaking CCL20/CCR6 axis through its vital active group targeting GUSB/ATF2 signaling (2024 · Phytomedicine · 被引 10)
• A genome-wide cross-trait analysis identifies shared loci and causal relationships of obesity and lipidemic traits with psoriasis (2024 · Frontiers in Immunology · 被引 10)
• Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907) (2025 · Gynecologic Oncology · 被引 9)
• The Benefit of the Optimized Formula of Yinxieling in Psoriasis Vulgaris via Regulation on Autophagy Based on microRNA Expression Profile and Network Pharmacology Analysis (2024 · Drug Design Development and Therapy · 被引 8)